MariMed shareholders approve 1-for-50 to 1-for-100 reverse stock split
MRMD•MariMed shareholders approved a reverse stock split at a ratio between 1-for-50 and 1-for-100. The board retains discretion over the timing, implementation and final ratio.
1. Board retains discretion
Shareholders approved the proposal on October 28, 2026. The board will decide whether and when to implement the split and choose the final ratio, potentially considering requirements for a U.S. national securities exchange listing. Fractional shares would be paid in cash; otherwise, proportional ownership and voting power would remain unchanged.
